234 related articles for article (PubMed ID: 28325651)
1. Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012).
Purnell S; Sidana A; Maruf M; Grant C; Agarwal PK
Urol Oncol; 2017 Jul; 35(7):457.e9-457.e14. PubMed ID: 28325651
[TBL] [Abstract][Full Text] [Related]
2. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort.
Sanchez A; Rodríguez D; Allard CB; Bechis SK; Sullivan RJ; Boeke CE; Kuppermann D; Cheng JS; Barrisford GW; Preston MA; Feldman AS
Urol Oncol; 2016 Apr; 34(4):166.e7-14. PubMed ID: 26739672
[TBL] [Abstract][Full Text] [Related]
3. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
Goffredo P; Sosa JA; Roman SA
J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
[TBL] [Abstract][Full Text] [Related]
4. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
5. Genetics and the clinical approach to paragangliomas.
Schulte KM; Talat N; Galata G; Aylwin S; Izatt L; Eisenhofer G; Barthel A; Bornstein SR
Horm Metab Res; 2014 Dec; 46(13):964-73. PubMed ID: 25014332
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
Aygun N; Uludag M
Sisli Etfal Hastan Tip Bul; 2020; 54(2):159-168. PubMed ID: 32617052
[TBL] [Abstract][Full Text] [Related]
7. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations.
Mora J; Cascón A; Robledo M; Catala A
Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664
[TBL] [Abstract][Full Text] [Related]
8. Anatomic Location Is the Primary Determinant of Survival for Paragangliomas.
Fischer T; Gaitonde S; Jones M; Bandera B; Goldfarb M
Am Surg; 2017 Oct; 83(10):1132-1136. PubMed ID: 29391110
[TBL] [Abstract][Full Text] [Related]
9. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
Welander J; Söderkvist P; Gimm O
Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
[TBL] [Abstract][Full Text] [Related]
10. [Pediatric pheochromocytoma and paraganglioma: an update].
Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
[TBL] [Abstract][Full Text] [Related]
11. Adult genitourinary sarcoma: A population-based analysis of clinical characteristics and survival.
Nazemi A; Daneshmand S
Urol Oncol; 2020 May; 38(5):334-343. PubMed ID: 32094047
[TBL] [Abstract][Full Text] [Related]
12. Mandibular Lytic Lesion in Familial Paraganglioma Syndrome Type I: A Clinical Conundrum.
Sinha P; Yuen SN; Chernock RD; Haughey BH
Ann Otol Rhinol Laryngol; 2017 Aug; 126(8):615-618. PubMed ID: 28670912
[TBL] [Abstract][Full Text] [Related]
13. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
14. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
15. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
16. The genomic landscape of phaeochromocytoma.
Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
[TBL] [Abstract][Full Text] [Related]
17. Proportion of heritable paraganglioma cases and associated clinical characteristics.
Drovdlic CM; Myers EN; Peters JA; Baysal BE; Brackmann DE; Slattery WH; Rubinstein WS
Laryngoscope; 2001 Oct; 111(10):1822-7. PubMed ID: 11801952
[TBL] [Abstract][Full Text] [Related]
18. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
Waguespack SG; Rich T; Grubbs E; Ying AK; Perrier ND; Ayala-Ramirez M; Jimenez C
J Clin Endocrinol Metab; 2010 May; 95(5):2023-37. PubMed ID: 20215394
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
